the induction of antinuclear antibodies ( ana ) by d-penicillamine ( dp ) was studied in 148 patients with rheumatoid arthritis ( ra ) who had completed at least 30 weeks in a double blind trial which compared dp at doses 500 mg and 125 mg daily to placebo .
C0003873
rheumatoid arthritis
C0030817
dp